ZOLASTA

Zolasta 4mg contains the active substance Zoledronic Acid, which belongs to the important group of substances called bisphosphonates. It is primarily used to effectively reduce the amount of calcium in the blood in adult patients where it is excessively high due to the presence of a tumor. Tumors can unfortunately accelerate normal bone change in such a way that the release of calcium from bone is significantly increased; this specific condition is formally known as tumor-induced hypercalcemia (TIH). Additionally, this medication is also used to prevent serious bone complications in adult patients suffering from multiple myeloma and bone metastases (which refers to the spread of cancer from the primary site to the bone) from solid tumors, when used in addition to their standard cancer therapy.

Zolasta 4mg is also widely indicated to prevent or treat osteoporosis, a condition in which the bones become thin and weak and may break easily, particularly in women who have undergone menopause. Furthermore, it is also effectively used to treat osteoporosis in men. It serves as a treatment for Paget’s disease of bone, a condition in which the bones are abnormally soft and weak and may consequently become deformed, painful, or easily broken. Other important uses include treating or preventing osteoporosis in both men and women who are taking glucocorticoids (a corticosteroid medication that can sometimes cause osteoporosis as a side effect).

You should not take this injection if you are allergic to zoledronic acid, another bisphosphonate, or any other ingredients of this medicine, and it is also contraindicated if you are pregnant or breastfeeding. Before initiating the treatment, it is crucial to inform your physician if you have pre-existing kidney or liver problems, other bone diseases, or are experiencing pain, swelling, or numbness in your jaw. This medicine is not recommended for use in adolescents and children below the age of 18 years. It is important to understand that Zolasta 4mg is not a cancer chemotherapy agent and therefore will not slow or stop the spread of cancer itself. However, it can still be very effectively used to treat bone diseases in patients who also have cancer.